Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danusertib in Relapsed CML
NCT00335868Phase 2Unknown
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Mar 2007
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
Phase 2, open-label trial of danusertib in chronic myeloid leukemia (CML), sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: unknown.
02
Drugs
danusertib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00335868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335868.